Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase Ib/IIa Study of BAT5906 in Diabetic Macular Edema
NCT04772105Phase 2Completed
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Oct 2020
- Primary completion
- Nov 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of BAT5906 in diabetic macular edema (DME), sponsored by Bio-Thera Solutions, Ltd.. Started Oct 2020; status: completed.
02
Drugs
BAT5906
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT04772105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04772105.